Search results
Author(s):
Vikas Kapil
,
Ajay K Jain
,
Melvin D Lobo
Added:
3 years ago
Up to one-in-five treated hypertensive patients are deemed to be treatment resistant1-3 (on at least three different anti-hypertensive medication classes, including a diuretic)4-6 and have high cardiovascular risk.7-9 There is a paucity of high-quality evidence to suggest that the addition of a fourth line (or fifth, sixth line, etc.) medication is likely to bring either hypertension under…
View more
Catheter-based Renal Denervation
Author(s):
Philipp Lurz
,
Karl Fengler
Added:
3 years ago
Article
Author(s):
Lisa Brandon
,
Faisal Sharif
Added:
3 years ago
Resistant hypertension remains a serious clinical burden despite significant advances in cardiology and healthcare. Hypertension is a chronic condition without any available cure, with significant associated morbidity and mortality, and necessitates lifelong use of medications. It is multifactorial in origin, associated with genetics, lifestyle factors and the metabolic syndrome. Resistant…
View more
Renal Denervation Insights
Author(s):
Justin E Davies
,
Faisal Sharif
,
Oriol Rodriguez
,
et al
Added:
3 years ago
Video Series
Latest on Ultrasound Renal Denervation
Author(s):
Joost Daemen
,
Added:
1 year ago
Video Series
Author(s):
Uwe Schwarzwälder
,
Thomas Zeller
Added:
3 years ago
The first renal artery balloon angioplasties were performed by Felix Mahler in Berne and Andreas Grüntzig in Zurich in 1977 using self-made, bulky, coaxial balloon catheters.1,2 Until the beginning of the 1990s, balloon angioplasty was the only method of percutaneous treatment of renal artery stenosis (RAS) with satisfying acute and long-term results for angioplasty of stenoses caused by…
View more
Author(s):
William R Colyer Jr
,
Christopher J Cooper
Added:
3 years ago
Renal artery stenosis (RAS) is a common manifestation of atherosclerotic disease. Although the exact prevalence rate for the population as a whole is unknown, RAS is seen in a significant proportion of patients who present with another manifestation of atherosclerosis (Table 1).1–7 Despite this high degree of prevalence, the management of RAS, specifically the role of revascularisation, remains…
View more
Author(s):
Andrew SP Sharp
Added:
4 years ago
Prof Andrew Sharp (University Hospital of Wales, Cardiff, UK) discusses factors affecting lesion formation in RF renal denervation.
Filmed on site at TCT 2019 in San Francisco by Radcliffe Cardiology.
View more